Abstract
Everolimus-eluting stents (EES) may be associated with a lower risk of stent thrombosis compared to bare-metal stents (BMS), but it remains unclear if the difference in stent thrombosis translates into differences in myocardial infarction or cardiac death. Accordingly, we compared EES to BMS in randomized controlled trials (RCTs) of patients undergoing percutaneous coronary intervention (PCI) in a meta-analysis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
